Ameritas Investment Partners’s Heron Therapeutics HRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$32.3K Buy
15,618
+4,116
+36% +$8.52K ﹤0.01% 2451
2025
Q1
$25.3K Hold
11,502
﹤0.01% 2447
2024
Q4
$17.6K Hold
11,502
﹤0.01% 2686
2024
Q3
$22.9K Hold
11,502
﹤0.01% 2581
2024
Q2
$40.3K Buy
11,502
+4,374
+61% +$15.3K ﹤0.01% 2259
2024
Q1
$19.7K Hold
7,128
﹤0.01% 2568
2023
Q4
$12.1K Hold
7,128
﹤0.01% 2780
2023
Q3
$7.34K Hold
7,128
﹤0.01% 2917
2023
Q2
$8.27K Hold
7,128
﹤0.01% 2955
2023
Q1
$10.8K Hold
7,128
﹤0.01% 2708
2022
Q4
$20.2K Hold
7,128
﹤0.01% 2561
2022
Q3
$30K Hold
7,128
﹤0.01% 2303
2022
Q2
$19K Hold
7,128
﹤0.01% 2563
2022
Q1
$41K Hold
7,128
﹤0.01% 2171
2021
Q4
$65K Hold
7,128
﹤0.01% 1969
2021
Q3
$76K Hold
7,128
﹤0.01% 1859
2021
Q2
$111K Hold
7,128
﹤0.01% 1663
2021
Q1
$116K Sell
7,128
-613
-8% -$9.98K ﹤0.01% 1570
2020
Q4
$164K Hold
7,741
0.01% 1263
2020
Q3
$115K Hold
7,741
0.01% 1348
2020
Q2
$114K Buy
7,741
+516
+7% +$7.6K 0.01% 1332
2020
Q1
$85K Hold
7,225
﹤0.01% 1364
2019
Q4
$170K Buy
7,225
+940
+15% +$22.1K 0.01% 1191
2019
Q3
$116K Hold
6,285
0.01% 1376
2019
Q2
$117K Buy
6,285
+614
+11% +$11.4K 0.01% 1406
2019
Q1
$139K Hold
5,671
0.01% 1260
2018
Q4
$147K Hold
5,671
0.01% 1135
2018
Q3
$179K Buy
5,671
+352
+7% +$11.1K 0.01% 1157
2018
Q2
$207K Buy
5,319
+734
+16% +$28.6K 0.01% 1050
2018
Q1
$127K Buy
4,585
+1,041
+29% +$28.8K 0.01% 1337
2017
Q4
$64K Hold
3,544
﹤0.01% 1770
2017
Q3
$58K Hold
3,544
﹤0.01% 1791
2017
Q2
$49K Hold
3,544
﹤0.01% 1916
2017
Q1
$53K Buy
+3,544
New +$53K ﹤0.01% 1801